Results 1 to 10 of about 1,229,162 (345)

Acknowledgment to Reviewers of Vaccines in 2020

open access: yesVaccines, 2021
Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Vaccines maintains its standards for the high quality of its published papers [...]
Vaccines Editorial Office
doaj   +1 more source

Retraction: Walach et al. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines 2021, 9, 693

open access: yesVaccines, 2021
The journal retracts the article, The Safety of COVID-19 Vaccinations—We Should Rethink the Policy [...]
Vaccines Editorial Office
doaj   +1 more source

Expression of Concern: Walach et al. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines 2021, 9, 693

open access: yesVaccines, 2021
The journal is issuing this expression of concern to alert readers to significant concerns regarding the paper cited above [...]
Vaccines Editorial Office
doaj   +1 more source

Acknowledgment to the Reviewers of Vaccines in 2022

open access: yesVaccines, 2023
High-quality academic publishing is built on rigorous peer review [...]
Vaccines Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Vaccines in 2021

open access: yesVaccines, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Vaccines Editorial Office
doaj   +1 more source

Expression of Concern: Artigas-Jerónimo et al. A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model. Vaccines 2020, 8, 77

open access: yesVaccines, 2020
The Editorial Office of Vaccines has decided to issue the following Expression of Concern about the published paper: A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model [...]
Vaccines Editorial Office
doaj   +1 more source

A research agenda for malaria eradication: vaccines. [PDF]

open access: yesPLoS Medicine, 2011
Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality.
malERA Consultative Group on Vaccines
doaj   +1 more source

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Vaccine impact models against rotavirus disease (RD) and pneumococcal disease (PD) in low- and middle-income countries assume vaccine coverage based on other vaccines.
Alen Marijam   +7 more
doaj   +1 more source

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors

open access: yesEMBO Molecular Medicine, 2021
Respiratory syncytial virus (RSV) is the leading cause of death from lower respiratory tract infection in infants and children, and is responsible for considerable morbidity and mortality in older adults. Vaccines for pregnant women and elderly which are
Emanuele Andreano   +14 more
doaj   +1 more source

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment [PDF]

open access: yes, 2014
There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic ...
Achilefu, Samuel   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy